Brief: Addex Therapeutics Q3 Operating Loss at CHF 2.7 million
29/11/2023 06:07
Nov 29 (Reuters) - Addex Therapeutics Q3 EPS CHF -0.03. * Q3 operating income CHF -2.652 million * Q3 net income CHF -2.617 million
Recent news on Addex Therapeutics
See all newsBrief: Addex Spin-Out Neurosterix Completes Phase 1 Clinical Studies Of NTX-253 For Schizophrenia
NASDAQ RESUMED AT 11:29 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:24 AM
Switzerland's Addex Therapeutics Q2 net loss narrows on decline in R&D expenses
Brief: Addex Therapeutics Q2 Operating Income CHF -645 Thousand